120 Recruiting Metastatic Breast Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Metastatic Breast Cancer Studies
Assessing the Time Demands of Cancer
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
📍 Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario — Kingston, Ontario
View Study & Checklist ➔A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
📍 Jacinto Convit World Organization, Inc. — Pompano Beach, Florida
View Study & Checklist ➔Scalp Cooling in MBC
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
📍 Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
📍 Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
View Study & Checklist ➔BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
📍 Loyola University — Maywood, Illinois
View Study & Checklist ➔Pulsed Electric Field Ablation for Metastatic Breast Cancer
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
📍 Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
📍 Emory University — Atlanta, Georgia
View Study & Checklist ➔The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
📍 Mayo Clinic - Scottsdale — Scottsdale, Arizona
View Study & Checklist ➔A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
📍 Research Site — Commack, New York
View Study & Checklist ➔Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
📍 University of California, San Diego — San Diego, California
View Study & Checklist ➔Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
📍 Kimmel Cancer Center at Johns Hopkins at Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
📍 Banner Health MD Anderson AZ — Gilbert, Arizona
View Study & Checklist ➔Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor
📍 PNAF Medical — Colorado Springs, Colorado
View Study & Checklist ➔Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
📍 The Oncology Institute of Hope and Innovation — Cerritos, California
View Study & Checklist ➔Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
📍 The University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔Roll-over Study to Allow Continued Access to Ribociclib
📍 Ironwood Cancer and Research Centers — Chandler, Arizona
View Study & Checklist ➔Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States
📍 Ridgefield — Ridgefield, Connecticut
View Study & Checklist ➔Palbociclib After CDK and Endocrine Therapy (PACE)
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
📍 Research Site — Fort Myers, Florida
View Study & Checklist ➔Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners
📍 University of Rochester — Rochester, New York
View Study & Checklist ➔A Study of HLD-0117 in Patients With Metastatic Breast Cancer
📍 Yale University School Of Medicine — New Haven, Connecticut
View Study & Checklist ➔Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
📍 City of Hope - Phoenix ( Site 0006) — Goodyear, Arizona
View Study & Checklist ➔Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
📍 James Graham Brown Cancer Center — Louisville, Kentucky
View Study & Checklist ➔Couples' QOL in Metastatic Breast Cancer
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
📍 Research Facility — Phoenix, Arizona
View Study & Checklist ➔Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔